IL33 and myocarditis: Although the mechanism has not yet been elucidated, the difference in cardiac function and survival/HF between TLR3- and TRIF-deficient mice suggests that TLR4-mediated TRIF may be responsible for reducing the negative cardiac effects of IL-33 in the heart during acute CVB3 myocarditis.